Table 3.
Absence complete response and complete protection per chemotherapy and phase
| Overall (%) | Carboplatin (%) | CRC (oxa/iri) (%) | |
|---|---|---|---|
| Total period | |||
| Absence complete response | 31.1 | 34.2 | 23.5 |
| Absence complete protection | 37.6 | 39.2 | 32.9 |
| Acute phase | |||
| Absence complete response | 15.8 | 23.5 | 6.0 |
| Absence complete protection | 20.5 | 25.9 | 13.1 |
| Delayed phase | |||
| Absence complete response | 23.0 | 23.5 | 19.1 |
| Absence complete protection | 31.2 | 34.3 | 26.4 |
Absence complete response: with emesis or use of rescue medication; Absence complete protection: emesis or significant nausea or use of rescue medication